ChanRx Corp. Receives $250,000 New Financing Round

  • Feed Type
  • Date
    8/5/2010
  • Company Name
    ChanRx Corp.
  • Mailing Address
    Undisclosed Garfield Heights, OH 44105
  • Company Description
    The company is developing small molecule drugs to treat atrial fibrillation.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $250,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company will use the money to complete development of its intravenous version of its drug called Vanoxerine.
  • M&A Terms
  • Venture Investor
    Jumpstart, Inc.

By posting a comment, you agree to our terms and conditions.